Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    conatumumab
Show Display Options
Rank Status Study
1 Active, not recruiting QUILT-3.030: Open Label Extension Study of Conatumumab and AMG 479
Conditions: Advanced Solid Tumors;   Carcinoid;   Colorectal Cancer;   Locally Advanced;   Lymphoma;   Metastatic Cancer;   Non-Small Cell Lung Cancer;   Sarcoma;   Solid Tumors
Interventions: Drug: FOLFOX6;   Biological: Conatumumab;   Biological: Ganitumab;   Biological: Bevacizumab
2 Completed Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
Conditions: Relapsed Epithelial Ovarian Cancer;   Relapsed Primary Peritoneal Cancer;   Relapsed Fallopian Tube Cancer
Interventions: Drug: Birinapant;   Drug: Conatumumab
3 Completed
Has Results
Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study
Conditions: Colon Cancer;   Colorectal Cancer;   Rectal Cancer;   Metastatic Colorectal Cancer;   Oncology
Interventions: Drug: Panitumumab;   Drug: Conatumumab
4 Withdrawn Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: conatumumab;   Drug: capecitabine;   Drug: gemcitabine hydrochloride;   Radiation: 3-dimensional conformal radiation therapy
5 Completed QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma
Condition: Metastatic Colorectal Cancer
Interventions: Other: FOLFIRI;   Biological: AMG 655;   Other: Placebo;   Biological: AMG 479
6 Completed Phase 1b/2 Study of AMG 655 With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma
Conditions: Locally Advanced or Metastatic, Unresectable Soft Tissue Sarcoma;   Sarcoma;   Soft Tissue Sarcoma
Interventions: Drug: AMG 655;   Other: Placebo;   Drug: Doxorubicin
7 Terminated QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors
Conditions: Colorectal Cancer;   Locally Advanced;   Metastatic Cancer;   Non-Small Cell Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer;   Sarcoma;   Solid Tumors
Interventions: Biological: AMG 479;   Biological: AMG 655

Study has passed its completion date and status has not been verified in more than two years.